|
| 38036767 | BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance. | Nat Immunol | 2024 |
| 37163615 | Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine. | Sci Transl Med | 2023 |
| 37798288 | Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates. | Nat Commun | 2023 |
| 37776858 | Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth. | Cell | 2023 |
| 36778389 | Systems biological assessment of the temporal dynamics of immunity to a viral infection in the first weeks and months of life. | medRxiv | 2023 |
| 36711543 | Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2. | bioRxiv | 2023 |
| 36951954 | Durability of immune responses to mRNA booster vaccination against COVID-19. | J Clin Invest | 2023 |
| 37069151 | A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates. | Nat Commun | 2023 |
| 36996809 | Spheromers reveal robust TÂ cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8<sup>+</sup> TÂ cell responses post SARS-CoV-2 infection. | Immunity | 2023 |
| 37225997 | Addendum: Systems vaccinology of the BNT162b2 mRNA vaccine in humans. | Nature | 2023 |
| 35087093 | A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice. | Nat Commun | 2022 |
| 36239699 | Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study. | Elife | 2022 |
| 35988541 | Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice. | Cell Rep | 2022 |
| 35606518 | Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice. | NPJ Vaccines | 2022 |
| 35976993 | Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine. | Sci Transl Med | 2022 |
| 36482977 | Durability of immune responses to the booster mRNA vaccination against COVID-19. | medRxiv | 2022 |
| 36597527 | A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates. | bioRxiv | 2022 |
| 34983950 | Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates. | Cell Mol Immunol | 2022 |
| 35040666 | Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. | Sci Transl Med | 2022 |
| 35288714 | Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. | Nat Immunol | 2022 |
| 35025672 | Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses. | Sci Transl Med | 2022 |
| 35148837 | Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. | Cell | 2022 |
| 34619077 | Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines. | Cell | 2021 |
| 33851181 | mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition. | medRxiv | 2021 |
| 34252919 | Systems vaccinology of the BNT162b2 mRNA vaccine in humans. | Nature | 2021 |
| 34088785 | Immune responses to SARS-CoV-2 in the lung. | Thorax | 2021 |
| 33873199 | Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. | Nature | 2021 |
| 33556148 | The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection. | PLoS Pathog | 2021 |
| 33758839 | Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines. | bioRxiv | 2021 |
| 33594366 | Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates. | bioRxiv | 2021 |
| 32788292 | Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. | Science | 2020 |
| 32393800 | T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers. | Nat Med | 2020 |
| 29773649 | PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C. | Journal of Biological Chemistry | 2018 |
| 27658623 | Toll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA Vaccination. | Scientific Reports | 2016 |